Tensive Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 16

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.24M

  • Investors
  • 5

Tensive General Information

Description

Developer of vascularize biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's prostheses are porously implantable based on biodegradable synthetic biomaterials and fabricated with internal micro-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling patients to improve their quality of life and avoid recurrent and expensive surgical operations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Viale Ortles 22/4
  • 20139 Milan
  • Italy
+39 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tensive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 31-May-2018 $3.24M 00.000 Completed Generating Revenue
2. Early Stage VC 20-May-2016 00.000 00.000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view Tensive’s complete valuation and funding history, request access »

Tensive Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vascularize biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The
Therapeutic Devices
Milan, Italy
16 As of 2022
00.000
0000000000 00.000

00000

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
00000000000 0000000
Dallas, TX
00 As of 0000
0000
0000000000 0 0000

000000

e magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labor
00000000000 0000000
Rio de Janeiro, Brazil
000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tensive Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ideal Implant Venture Capital-Backed Dallas, TX 00 0000 0000000000 0 0000
0000000 Corporate Backed or Acquired Rio de Janeiro, Brazil 000 000.00 000000000 000.00
00 0000000000 Venture Capital-Backed Dublin, Ireland 000 00000 0000000000 0 00000
000ô0 Corporate Backed or Acquired Glasgow, United Kingdom 00 000000&0
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Tensive Patents

Tensive Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3594254-A1 Method of producing biocompatible and ecocompatible polyurethanes through the use of a hyperbranched-to-partially crosslinked polymeric precursor, and polyurethanes produced by said method Pending 13-Jul-2018 000000000
US-20190336271-A2 Biodegradable medical device for breast reconstruction and/or augmentation Active 02-Sep-2015 00000000
CA-2997384-A1 Biodegradable medical device for breast reconstruction and/or augmentation Pending 02-Sep-2015 00000000
EP-3344186-A1 Biodegradable medical device for breast reconstruction and/or augmentation Pending 02-Sep-2015 00000000
US-10743982-B2 Biodegradable medical device for breast reconstruction and/or augmentation Active 02-Sep-2015 A61F2/12
To view Tensive’s complete patent history, request access »

Tensive Executive Team (7)

Name Title Board Seat Contact Info
Federico Martello Ph.D Co-Founder, Chief Executive Officer & Chief Operating Officer
Alberto Cantaluppi MD Chairman & President
Valentina Morigi Co-Founder, Chief Financial Officer, President & Board Member
Alessandro Tocchio Ph.D Co-Founder, Chief Strategy Officer, Chief Strategist & Board Member
Irini Gerges Ph.D Co-Founder, Chief Technology Officer & Director, Research & Development & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Tensive Board Members (5)

Name Representing Role Since
Alberto Cantaluppi MD Tensive Chairman & President 000 0000
Alessandro Tocchio Ph.D Tensive Co-Founder, Chief Strategy Officer, Chief Strategist & Board Member 000 0000
Irini Gerges Ph.D Tensive Co-Founder, Chief Technology Officer & Director, Research & Development & Board Member 000 0000
Valentina Morigi Tensive Co-Founder, Chief Financial Officer, President & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Tensive Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tensive Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
CDP Venture Capital Venture Capital Minority 000 0000 000000 0
EASME - EU Executive Agency for SMEs Corporation Minority 000 0000 000000 0
UniCredit Investment Bank Minority 000 0000 000000 0
Seedlab Accelerator/Incubator 000 0000 000000 0
To view Tensive’s complete investors history, request access »